Business/rumor/2026-10-08

Isomorphic Labs Reportedly Seeks Funding at a Valuation of at Least $40 Billion

Isomorphic Labs, an AI drug discovery company spun out of Google DeepMind, is reportedly seeking new funding. Bloomberg reported that the company is in talks to raise funds at a valuation of at least $40 billion, with some reports suggesting a potential range up to $50 billion. This information is based on unnamed sources cited by Bloomberg.

4 articles from 3 outlets covered this story. The underlying claim is sourced from a rumor.

What do all outlets agree on?

3 outlets covered “Isomorphic Labs Reportedly Seeks Funding at a Valuation of at Least $40 Billion”. All of them report the following:

  • Isomorphic Labs is an AI drug discovery company
  • It is a spin-off from Google DeepMind/Alphabet
  • It is seeking or in talks for new funding
  • The valuation being discussed is at least $40 billion

Which figures do outlets report differently?

1 figure in this story is reported with conflicting values:

Valuation$40 Billion vs $40B–$50B vs at least $40 billion

Which outlets covered this?

All 4 articles found on this story, grouped by the stance of the piece. Every link goes to the original publisher.

What related stories are there?

Which companies does this involve?

Get the week in AI in one email

What happened, which outlets reported it, and where their coverage differed. One issue a week.

The first issue hasn’t gone out yet. Subscribe and it’s the one you’ll get.

We’ll send the digest and nothing else. One-click unsubscribe. Privacy.